Approved for Treatment of serious infections caused by multidrug-resistant organisms including ESBL-producing Enterobacterales and MRSA when alternatives are limited. Irreversibly inhibits the enzyme MurA (UDP-N-acetylglucosamine enolpyruvyl transferase), which catalyzes the first committed step of bacterial cell wall (peptidoglycan) synthesis. This mechanism is… Side effects, costs,…
Loading full data from Know Your Drugs Institute…